Allergy Diagnostics Market worth $9.8 billion by 2029
                     Allergy Diagnostics Market
Global Forecast to 2029
Allergy Diagnostics Market 
is expected to reach 
USD 9.8 billion by 2029 
 Growing at a 
CAGR of  11.0% (2024 – 2029)
SINGLE USE BIOPROCESSING MARKET 
MARKET 
CAGR of OPPORTUNITY OVER KEY MARKET PLAYERS BY TYPE 
2024 – 2029 NEXT 5 YEARS
$9.8Bn 
CAGR Thermo Fisher Scientific Inc.(US)$5.3  Consumables Siemens Healthineers AG (Germany)
Bn
  Danaher (US) Instruments
  Canon Inc. (Japan) Services
  Minaris Medical America Inc. (US)
2024 2029
  Eurofins Scientific (Luxembourg)
BY REGION BY ALLERGEN
• North America  Inhaled Allergens
• Europe Food Allergens
• Asia Pacific Drug Allergens
• Rest of the World Other Allergens
The size of global allergy diagnostics market in terms of revenue was estimated to be 
worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a 
CAGR of 11.0% from 2024 to 2029. The new research study consists of an industry 
trend analysis of the market. The new research study consists of industry trends, 
pricing analysis, patent analysis, conference and webinar materials, key stakeholders, 
and buying behaviour in the market.
The growth in this market is attributed to the increasing initiatives for allergy research 
and treatment, changing environment conditions, and growing healthcare 
expenditure. However, false positive test results and limited access to testing services 
could restrain the growth of this market.
Download PDF Brochure:
The allergy diagnostics market is dominated by players such as 
• Thermo Fisher Scientific Inc.(US)
•  Siemens Healthineers AG (Germany)
•  Danaher (US)
•  Canon Inc. (Japan)
•  Minaris Medical America Inc. (US)
•  Eurofins Scientific (Luxembourg)
•  EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (Germany)
•  bioMérieux SA (France)
•  Stallergenes Greer Ltd. (UK)
•  HollisterStier Allergy (US)
•  and Omega Diagnostics Group PLC (UK)
In 2023, North America to dominate in Allergy Diagnostics industry.
The global allergy diagnostics market is segmented into North America, Europe, Asia 
Pacific, Latin America, and the Middle East & Africa. North America is expected to 
dominate during the forecast period, primarily due to the growing availability of 
government funding for allergy research activities, the presence of major players in 
the US, presence of telemedicine & remote testing, and increased collaborations and 
partnerships between government and allergy associations. 
Request Sample Pages
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
UK +44-800-368-9399
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/